Cargando…
Dexamethasone and Nutraceutical Therapy Can Reduce the Myalgia Due to COVID-19 – a Systemic Review of the Active Substances that Can Reduce the Expression of Interlukin-6
BACKGROUND: Myalgia reflects generalized inflammation and cytokine response and can be the onset symptom of 36% of patients with COVID-19. Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF- α) levels in plasma and upper respiratory secretions directly correlate with the magnitude of viral replic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976893/ https://www.ncbi.nlm.nih.gov/pubmed/35422571 http://dx.doi.org/10.5455/medarh.2022.76.66-71 |